Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Gp₄G promotes hair growth and improves skin health.

Emulgel improves skin delivery of various drugs better than traditional methods.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

Tideglusib with a bacterial cellulose hydrogel improves wound healing in rats.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Tofacitinib helped regrow hair in a woman with alopecia areata.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

The new nasal gel for schizophrenia improved drug absorption and brain effects in rats.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Entospletinib effectively prevents eye and skin GVHD in mice.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Dermoscopy helped diagnose a rare skin disease which slightly improved with treatment.

Ursolic acid may help develop new anti-inflammatory drugs by affecting immune cells.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Baricitinib improved hair loss and arthritis in a lupus patient.